Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TNIK Antikörper (AA 553-886)

Der Kaninchen Polyklonal anti-TNIK Antikörper (ABIN7875715) detektiert spezifisch TNIK in ELISA, WB, IHC, FACS, ICC und IF. Dieser Antikörper reagiert spezifisch mit Proben aus Human und Maus.
Produktnummer ABIN7875715
644,88 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für TNIK Antikörper (AA 553-886) (ABIN7875715)

Target

Alle TNIK Antikörper anzeigen
TNIK (TRAF2 and NCK Interacting Kinase (TNIK))

Reaktivität

  • 75
  • 68
  • 39
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus

Wirt

  • 102
  • 4
Kaninchen

Klonalität

  • 102
  • 4
Polyklonal

Konjugat

  • 43
  • 8
  • 7
  • 7
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser TNIK Antikörper ist unkonjugiert

Applikation

  • 41
  • 39
  • 27
  • 27
  • 23
  • 17
  • 10
  • 7
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF)
  • Bindungsspezifität

    • 24
    • 15
    • 12
    • 8
    • 6
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 553-886

    Verwendungszweck

    TNIK Antibody / Traf2 and Nck-interacting kinase

    Aufreinigung

    Immunogen affinity purified

    Immunogen

    E.coli-derived human TNIK recombinant protein (Position: H553-E886) was used as the immunogen for the TNIK antibody.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal dilution of the TNIK antibody should be determined by the researcher.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    After reconstitution, the TNIK antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
  • Target

    TNIK (TRAF2 and NCK Interacting Kinase (TNIK))

    Andere Bezeichnung

    TNIK

    Hintergrund

    TNIK antibody detects Traf2 and Nck-interacting kinase, encoded by the TNIK gene on chromosome 3q26.32. TNIK antibody is widely used to study this serine/threonine kinase of the germinal center kinase family, which integrates multiple signaling pathways regulating cytoskeletal organization, transcription, and cell fate. TNIK was originally identified as a binding partner of the TNF receptor adaptor Traf2 and the adaptor protein Nck, linking it to stress and growth factor pathways. It is expressed in many tissues, including brain, gastrointestinal tract, and immune cells, and plays key roles in neuronal development, cancer biology, and Wnt signaling.

    Structurally, TNIK contains an N-terminal kinase domain, a coiled-coil domain, and a C-terminal citron homology domain. These regions enable TNIK to interact with multiple proteins, including beta-catenin, TCF4, and signaling adaptors. Its kinase domain phosphorylates downstream effectors that regulate actin cytoskeleton remodeling, while its scaffold domains recruit transcription factors and signaling molecules. This modular structure allows TNIK to act as both a kinase and adaptor, coordinating signaling complexes.

    Functionally, TNIK is a central regulator of Wnt/beta-catenin signaling. It forms complexes with TCF4 and beta-catenin, phosphorylating transcriptional cofactors to drive expression of Wnt target genes. This activity is critical for stem cell maintenance, proliferation, and differentiation. TNIK also regulates actin cytoskeleton dynamics through Rho family GTPase signaling, influencing cell adhesion, migration, and polarity. In neurons, TNIK contributes to dendritic spine development, synaptic signaling, and memory formation. Knockout and knockdown studies reveal that TNIK deficiency impairs brain development and cognitive function.

    Clinically, TNIK is strongly implicated in cancer. Overexpression is observed in colorectal, gastric, and hepatocellular carcinomas, where it sustains aberrant Wnt activity and tumor progression. Inhibiting TNIK suppresses tumor growth in preclinical models, making it a potential therapeutic target. TNIK has also been linked to psychiatric conditions, including schizophrenia, where altered expression and signaling affect neuronal pathways. Researchers rely on TNIK antibody to study its function in transcriptional regulation, cytoskeletal control, and disease progression.

    Experimentally, TNIK antibody is used in western blotting to detect the ~160 kDa protein, in immunofluorescence to examine subcellular localization, and in immunohistochemistry to map tissue-specific expression. Co-immunoprecipitation with TNIK antibody identifies binding partners including beta-catenin and TCF4, confirming its role in Wnt transcriptional complexes. NSJ Bioreagents provides TNIK antibody to support research in cancer biology, neuroscience, and developmental signaling.

    UniProt

    Q9UKE5
Sie sind hier:
Chat with us!